• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类身高的遗传基础。

The genetic basis of human height.

作者信息

Bicknell Louise S, Hirschhorn Joel N, Savarirayan Ravi

机构信息

Department of Biochemistry, University of Otago, Dunedin, New Zealand.

Division of Endocrinology, Boston Children's Hospital, Boston, MA, USA.

出版信息

Nat Rev Genet. 2025 Apr 7. doi: 10.1038/s41576-025-00834-1.

DOI:10.1038/s41576-025-00834-1
PMID:40189669
Abstract

Human height is a model polygenic trait - additive effects of many individual variants create continuous, genetically determined variation in this phenotype. Height can also be severely affected by single-gene variants in monogenic disorders, often causing severe alterations in stature relative to population averages. Deciphering the genetic basis of height provides understanding into the biology of growth and is also of relevance to disease, as increased or decreased height relative to population averages has been epidemiologically and genetically associated with an altered risk of cancer or cardiometabolic diseases. With recent large-scale genome-wide association studies of human height reaching saturation, its genetic architecture has become clearer. Genes implicated by both monogenic and polygenic studies converge on common developmental or cellular pathways that affect stature, including at the growth plate, a key site of skeletal growth. In this Review, we summarize the genetic contributors to height, from ultra-rare monogenic disorders that severely affect growth to common alleles that act across multiple pathways.

摘要

人类身高是一种典型的多基因性状——许多个体变异的累加效应导致了这一表型的连续、由基因决定的变异。身高也会受到单基因疾病中单基因变异的严重影响,相对于人群平均水平,这些变异通常会导致身材发生严重改变。解读身高的遗传基础有助于理解生长生物学,并且与疾病也相关,因为相对于人群平均水平,身高的增加或减少在流行病学和遗传学上都与患癌风险或心脏代谢疾病的改变有关。随着近期关于人类身高的大规模全基因组关联研究趋于饱和,其遗传结构已变得更加清晰。单基因和多基因研究涉及的基因都集中在影响身高的共同发育或细胞途径上,包括生长板,这是骨骼生长的关键部位。在本综述中,我们总结了影响身高的遗传因素,从严重影响生长的超罕见单基因疾病到作用于多种途径的常见等位基因。

相似文献

1
The genetic basis of human height.人类身高的遗传基础。
Nat Rev Genet. 2025 Apr 7. doi: 10.1038/s41576-025-00834-1.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
- and -Related Osteogenesis Imperfecta与……相关的成骨不全症 (你提供的原文不完整,推测这里可能是想表达“某种因素与成骨不全症相关”,但仅从现有的“- and -Related Osteogenesis Imperfecta”很难准确翻译出完整准确的内容,以上是基于可能情况的翻译 )
4
Can We Accurately Predict Adult Height in Pediatric Patients Who Undergo Treatment for Sarcoma?我们能否准确预测接受肉瘤治疗的儿科患者的成人身高?
Clin Orthop Relat Res. 2025 Feb 6;483(7):1338-46. doi: 10.1097/CORR.0000000000003409.
5
Short-Term Memory Impairment短期记忆障碍
6
MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.马克 VCID 脑小血管联盟:一、入组、临床、液体方案。
Alzheimers Dement. 2021 Apr;17(4):704-715. doi: 10.1002/alz.12215. Epub 2021 Jan 21.
7
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
8
Phenome-wide association study identifies multiple traits associated with a polygenic risk score for colorectal cancer.全表型关联研究确定了与结直肠癌多基因风险评分相关的多个性状。
Hum Genomics. 2025 Jul 9;19(1):77. doi: 10.1186/s40246-025-00791-0.
9
Isolated Methylmalonic Acidemia孤立性甲基丙二酸血症
10
Dystrophic Epidermolysis Bullosa营养不良性大疱性表皮松解症

引用本文的文献

1
Autoimmune thyroid disease and pituitary adenoma in a female patient with 18p deletion syndrome: a case report and review of the literature.一名患有18p缺失综合征女性患者的自身免疫性甲状腺疾病和垂体腺瘤:病例报告及文献复习
BMC Endocr Disord. 2025 Aug 25;25(1):199. doi: 10.1186/s12902-025-02017-9.

本文引用的文献

1
A multi-omic atlas of human embryonic skeletal development.人类胚胎骨骼发育的多组学图谱。
Nature. 2024 Nov;635(8039):657-667. doi: 10.1038/s41586-024-08189-z. Epub 2024 Nov 20.
2
Oral Infigratinib Therapy in Children with Achondroplasia.儿童软骨发育不全的口服英菲格拉替尼治疗
N Engl J Med. 2025 Feb 27;392(9):865-874. doi: 10.1056/NEJMoa2411790. Epub 2024 Nov 18.
3
Whole-genome sequencing in 333,100 individuals reveals rare non-coding single variant and aggregate associations with height.对 333100 个人进行全基因组测序,揭示了罕见的非编码单变体和与身高相关的综合关联。
Nat Commun. 2024 Oct 3;15(1):8549. doi: 10.1038/s41467-024-52579-w.
4
A Genomics England haplotype reference panel and imputation of UK Biobank.英国基因组学公司单倍型参考面板和英国生物库的基因分型。
Nat Genet. 2024 Sep;56(9):1800-1803. doi: 10.1038/s41588-024-01868-7. Epub 2024 Aug 12.
5
Skeletal abnormalities in mice with Dnmt3a missense mutations.Dnmt3a 错义突变小鼠的骨骼异常。
Bone. 2024 Jun;183:117085. doi: 10.1016/j.bone.2024.117085. Epub 2024 Mar 23.
6
New treatments for children with achondroplasia.针对软骨发育不全患儿的新疗法。
Lancet Child Adolesc Health. 2024 Apr;8(4):301-310. doi: 10.1016/S2352-4642(23)00310-3.
7
The roles and regulatory mechanisms of TGF-β and BMP signaling in bone and cartilage development, homeostasis and disease.转化生长因子-β(TGF-β)和骨形态发生蛋白(BMP)信号在骨骼和软骨发育、稳态及疾病中的作用和调控机制。
Cell Res. 2024 Feb;34(2):101-123. doi: 10.1038/s41422-023-00918-9. Epub 2024 Jan 24.
8
Vosoritide therapy in children with achondroplasia aged 3-59 months: a multinational, randomised, double-blind, placebo-controlled, phase 2 trial.在 3-59 个月大的软骨发育不全儿童中进行 Vosoritide 治疗:一项多中心、随机、双盲、安慰剂对照的 2 期试验。
Lancet Child Adolesc Health. 2024 Jan;8(1):40-50. doi: 10.1016/S2352-4642(23)00265-1. Epub 2023 Nov 18.
9
Growth reference charts for children with hypochondroplasia.软骨发育不全患儿生长参考图表。
Am J Med Genet A. 2024 Feb;194(2):243-252. doi: 10.1002/ajmg.a.63431. Epub 2023 Oct 9.
10
Identification and analysis of individuals who deviate from their genetically-predicted phenotype.鉴定和分析与遗传预测表型不符的个体。
PLoS Genet. 2023 Sep 21;19(9):e1010934. doi: 10.1371/journal.pgen.1010934. eCollection 2023 Sep.